Endpoint-aligned artificial intelligence for biopsy-sparing assessment of suspected basal cell carcinoma

Basal cell carcinoma (BCC) care follows a sequence of decisions from triage to pathological subtyping and depth assessment, and the information available changes at each step. To date, no artificial-intelligence (AI) tool using non-invasive inputs has been developed to support this full decision-making sequence. In this study, we developed a multi-endpoint AI framework matching non-invasive inputs to each decision point in 1,459 internal and 995 external patients.